HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

China · Delayed Price · Currency is CNY

9.43

+0.10 (1.07%)

Sep 30, 2026, 3:00 PM CST

Market Cap	5.47B +19.2%
Revenue (ttm)	10.64B +4.2%
Net Income	142.26M -5.6%
EPS	0.25 -5.6%
Shares Out	579.89M
PE Ratio	38.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,904,682
Open	9.32
Previous Close	9.33
Day's Range	9.31 - 9.55
52-Week Range	7.54 - 18.13
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers chemical drugs, traditional Chinese medicine, biological products, and medical supplies; medical instruments, traditional Chinese medicine decoction pieces, health foods, daily necessities, glassware, and chemical reagents, etc.; It serves its products through e-commerce platforms, direct sales, and a chain of direct stores and online B2C, O2O, etc. The company was founded in 1950 and is h... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1950

Employees 2,735

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600829

Full Company Profile

Financial Performance

In 2025, SHA:600829's revenue was 10.38 billion, an increase of 3.29% compared to the previous year's 10.05 billion. Earnings were 133.84 million, a decrease of -37.24%.

Financial Statements